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The editor of the Journal received a printout of an article that
appeared in a news column on ABCNEWS.com which criticized the
scientific community for advocating the theory that the current
epidemic of chronic hepatitis C is caused by a virus based on flawed
scientific fundamentals. The article was sent to him by two of his
patients who obviously were concerned about this and its ramifica
tions.
The issues raised by the author, Mr. Nicholas Regush, are the
following:
1. The virus C has never been isolated in an intact form.
2. The virus has never been grown successfully in a cell culture.
3. No animal model of hepatitis C caused by injecting this virus has
been established.
4. No one has documented that this virus is infectious.
In other words the Koch’s principles were not met, and therefore to
claim that the current candidate HCV-RNA genome reconstructed
through molecular engineering techniques is scientifically unsound
and to advocate it to be “the” virus which caused the chronic
hepatitis is flawed.
The “virus” that caused the post-transfusion non-A non-B hepa
titis has been suspected to be in existence since early 1970’s.
Through many researchers’ works, it is known that this agent or
agents that caused this disease are filterable and likely to be RNA
virus. The scientists from NIH blood bank and CDC virology section
had been collecting plasmas from several chimpanzees that had been
repeatedly infected by patient’s serum who are believed to be
infected by these agents. These plasma were all labeled and kept by
Dr. Harvey Alter. For many years since 1975, there were many
laboratories around the world sent samples of the agent they be
lieved to be the virus that cause the hepatitis. But all failed the tests
set up by Dr. Harvey Alter. In 1987, the Chiron Corp. scientists
finally identified an antigen that is a fragment of genetically engi
neered protein product they had identified through a tedious isola
tion process from infected chimpanzees’ plasma. This antigen was
able to capture a specific antibody circulating in patients with
chronic hepatitis due to transfusion. The antigen was then used to
develop a serology test. Dr. Alter then tested the serums kept. The
results were published in the Science magazine in 1987. Since then
many different laboratories in the world were able to reproduce their
findings and the entire genome of this RNA virus was mapped. It is
a fact that so far there is no cell culture system in existence to
propagate the virus but it has been visualized in the endoplasmic
reticulum of infected liver cells under electron microscope. And
recently there are two articles published have proved that the full-
length complementary DNA clone of HCV can transmit hepatitis in
the animal model—chimpanzees)’2In addition, there were many
clinical evidences which strongly suggested that this is a real agent
which caused about 80-.90% of the so-called post-transfusion non-
A non-B in the U.S. For instance, both in the U.S. and Japan, the
incidence and prevalence ofpost-transfusion hepatitis C have plunged
since the implementation of a screening test for all donated blood.
This is a further decline more than the HIV screening of the blood
has provided as suggested in the article. This is especially true in
Japan where HIV infection is much less than the U.S. Furthermore,
clinical experience in my own practice and many of my colleagues
who are also engaged in the treatment of chronic hepatitis C,
eradication of the HCV-RNA material from serum has not only
normalized their liver enzymes but also improved or normalized
their hepatic histo-pathology. For those unfortunate patients who
relapsed after eradication of the virus, their liver enzymes and liver
histology also showed recurrence. These are convincing evidences
to implicate that the HCV-RNA is indeed the cause of the hepatitis.
I was able to contact and speak with Dr. Richard Strohman, a
molecular biologist at UC Berkeley quoted in the news column. He
was very kind in agreeing to discuss with me the issues of his
concerns. I believe Dr. Stohman has a point in pure scientific merit
that the current scientific evidences, especially without a cultural
system and proper animal model, are weak and need more studies to
prove beyond any doubt that the HCV-RNA is indeed the cause of
hepatitis C. But he agreed with me that this scientific impurity
should not stop us, the clinicians, to use this HCV-RNA as a
surrogate marker to treat our patients who are at risk of developing
end-stage liver disease and hepatic-cellular cancer. And the patients
who suffer from chronic hepatitis C should also be aware that the
article is arguing for the proper scientific evidences and not that the
disease is not in existence. Though personally, I do believe we have
the right virus. And the recent studies has shown encouraging
evidence that the culture system for the virus may become available
before too long.
My qualm with the ABC columnist is that he used sensational
language and rhetoric in his article which is, I believe, intended for
general audiences who are not savvy in molecular sciences and
created a false impression that current chronic hepatitis C disease is
nothing but a shibai played by the scientific and medical community
in conjunction with pharmaceutical industry for profit. I think this is
not what he intended as can be seen in the first paragraph of his
article. Scientific news reporting and commenting professionals
should take particular care not to mislead readers. This can occur
even with careful footnoting, therefore, eye-catching sensational
language really have no place in scientific/medical reporting.
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